Viewing Study NCT00027261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:02 PM
Ignite Modification Date: 2025-12-30 @ 1:18 PM
Study NCT ID: NCT00027261
Status: COMPLETED
Last Update Posted: 2021-10-14
First Post: 2001-11-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None HIV Seronegativity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccines, Synthetic View
None HIV-1 View
None AIDS Vaccines View
None CD8-Positive T-Lymphocytes View
None HIV Seronegativity View
None Avipoxvirus View
None Dose-Response Relationship, Immunologic View
None HIV Preventive Vaccine View